Search

everythinglearnresearchcommunity

for

Search:↓

Platelet-rich plasma therapy shows promise for hair regrowth in alopecia patients.

Amphetamine use may not cause hair loss, "geezer" traits are normal aging, not all educated older people are stereotypes, and metronidazole can rarely cause lung disease.

Intralesional triamcinolone acetonide is effective for treating patchy hair loss, and dermoscopy helps detect treatment response and side effects early.

The article concludes that treating hair loss requires careful research, understanding the causes, and personalized treatment plans.

Female pattern hair loss in women is caused by hormones and genetics, leading to hair thinning, with various treatments available.

Combining a GnRH agonist with a low-dose oral contraceptive is more effective and safer for treating hirsutism than using either alone.

The treatment effectively promotes hair growth and is well-tolerated.

Women with hair loss should be checked for PCOS, as it's often related and early diagnosis can help with treatment.

The document concludes that female pattern baldness involves hair thinning, is classified differently than in men, and is assessed using the Ludwig classification. It also explains the hair growth cycle stages.

Androgenetic alopecia, a common hair loss condition, can be treated with topical minoxidil, oral finasteride, or oral spironolactone, and new treatments like platelet-rich plasma, low-level laser therapy, and janus-kinase inhibitors are being explored.

Ulerythema ophryogenes causes hair thinning and inflammation, with limited treatment options.

Changes in scalp microbes may contribute to hair loss, suggesting new treatment options.

Fibrosis contributes to hair loss in androgenetic alopecia, and targeting it may improve treatment.

Hair thinning improved with basalt stone and placenta extract treatment but recurred when paused.

Hormonal therapies help treat female hair loss, but results are slow and vary.

The document concludes that early diagnosis is key for treating common baldness in women, but reassurance is often the best approach as hair thinning can be a normal part of aging.

The document concludes that patients with skin of color need specialized dermatological care and education to manage unique skin conditions effectively.

Topical treatments can deliver active molecules to skin stem cells, potentially helping treat skin and hair disorders, including skin cancers and hair loss.

Estrogen deficiency in postmenopausal women can cause skin and hair issues, but local estrogen therapies help improve vaginal health.

Tick-bite alopecia can be identified by a bite-centered mark and treated with topical steroids, while SENLAT needs doxycycline.

Early treatment of COVID-19-related hair loss is crucial for better outcomes.

The machine learning model effectively assesses the severity of hair loss and could help dermatologists with treatment decisions.

Mimicking growth factors in a topical solution can prolong hair growth phase and reduce hair loss without side effects.

Frontal fibrosing alopecia is a scarring hair loss condition mainly affecting older women, with no known cause and treatments that may help stabilize hair loss.

Early diagnosis of alopecia frontal fibrosante is crucial, but treatment remains controversial and varies.

Phytochemicals in hair masks can help with damaged hair, seborrhea, and hair loss.

Hair transplantation is a viable treatment for some types of female hair loss, with careful donor assessment and attention to psychological factors.

Female pattern hair loss is caused by genetics and hormones, leading to hair thinning in women.

Hair diameter diversity could improve androgenetic alopecia assessment and treatment planning.

Androgenic alopecia causes hair thinning, and treatments include minoxidil, finasteride, and light therapy.